NPI: 1457316085 · VIENNA, WV 26105 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/18/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/18/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,959 | $76K |
| 2019 | 9,461 | $62K |
| 2020 | 8,249 | $77K |
| 2021 | 3,716 | $35K |
| 2022 | 381 | $644.38 |
| 2023 | 873 | $16K |
| 2024 | 132 | $2K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,086 | 1,113 | $200K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,484 | 763 | $59K |
| J1756 | Injection, iron sucrose, 1 mg | 2,517 | 720 | $3K |
| A4657 | Syringe, with or without needle, each | 1,037 | 893 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,543 | 326 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 669 | 642 | $159.52 |
| 83970 | 510 | 470 | $148.57 | |
| 82108 | 259 | 244 | $49.93 | |
| 82728 | 407 | 377 | $45.26 | |
| 83550 | 403 | 372 | $28.59 | |
| 85045 | 853 | 696 | $20.71 | |
| 83540 | 400 | 370 | $20.21 | |
| 85041 | 715 | 688 | $13.72 | |
| 85048 | 730 | 688 | $11.81 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 96 | 82 | $9.20 |
| 90674 | 32 | 31 | $0.71 | |
| G0008 | Administration of influenza virus vaccine | 30 | 29 | $0.62 |